V.M.D. is registered with the CBE as active in: Vervaardiging van geneesmiddelen. Public Limited, started on 30 November 1973, 1 establishment.

What is the address of V.M.D.?

The registered office of V.M.D. is located at Hoge Mauw 900, 2370 Arendonk.

Is V.M.D. still active?

Yes. According to the CBE (29 October 2026) V.M.D. is active, legal situation “Normale toestand”, started on 30 November 1973.

Is V.M.D. registered on Peppol?

Yes, V.M.D. is registered on the Peppol network with ID 0208:0413622648.

What is the enterprise number of V.M.D.?

The enterprise number of V.M.D. is BE0413622648.

When was V.M.D. founded?

V.M.D. was founded on 30 November 1973.

Who are the directors of V.M.D.?

According to the 2025 annual accounts, the directors of V.M.D. are: René Lindell, Niclas Lindstedt , Mikko Kemppainen.

Is V.M.D. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 November 1973; 4 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did V.M.D. make in 2025?

V.M.D. posted a profit after taxes of € 545,841 in financial year 2025.

What is the revenue of V.M.D.?

In its most recent annual accounts (2025), V.M.D. reported revenue of € 40,632,935.

How much does an employee at V.M.D. earn?

The average wage cost per full-time employee at V.M.D. was € 106,600 in 2025: staff costs of € 5.4 million for 50.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does V.M.D. have?

According to the 2025 annual accounts, V.M.D. has 50.5 full-time equivalents (FTE).

Does V.M.D. have a website?

Yes, V.M.D. has a website at inovet.eu.

V.M.D. (Public Limited) - Arendonk - BE0413622648

Dossier V.M.D., printed on 29 October 2026 from databakkes.be/en/0413622648/v-m-d. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2024.

Financials

Financial year 2025

V.M.D. from Arendonk, company number BE0413622648, closed financial year 2025 with a result of € 545,841 after tax. For that financial year V.M.D. recorded revenue of € 40.6 million and equity of € 2.7 million. Compared with financial year 2024, the result moved from € -25.8 million to € 545,841. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 27, 2026.

What it is worth Growing

€ 2.7 million

▲ € 12.5 million vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 545,841

▲ still € 25.8 million loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3.1 million

▼ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 2 million.

People and assets in 2025

Full-time equivalents

50.5

▲ 2.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 4.3 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 5.4 million

▲ 18% vs 2024

€ 106,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 237,775

▼ 32% vs 2024

Of which on lease € 137,805.

Debts at end 2025

Bank debt ≈ 232 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 15.4 million

▼ 37% vs 2024

€ 66,551 is repaid this year. At this pace the long-term loan is gone in ≈ 232 years.

Owed to suppliers

€ 3.7 million

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 40 days on average.

Taxes and wages

€ 1 million

▲ 83% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2023	2024	2025	Change 2024 → 2025
Revenue	€ 36,419,548 Revenue 2021: € 36,419,548 First fiscal year in the series	€ 28,894,103 Revenue 2023: € 28,894,103 ▼ 21% vs 2021 (€ 36,419,548) Unfavourable step	€ 34,964,982 Revenue 2024: € 34,964,982 ▲ 21% vs 2023 (€ 28,894,103) Favourable step	€ 40,632,935 Revenue 2025: € 40,632,935 ▲ 16% vs 2024 (€ 34,964,982) Favourable step	▲ 16%
Profit after taxes	€ 1,594,724 Profit after taxes 2021: € 1,594,724 First fiscal year in the series	€ -9,639,095 Profit after taxes 2023: € -9,639,095 ▼ € 11.2 million vs 2021 (€ 1,594,724) Unfavourable step	€ -25,766,670 Profit after taxes 2024: € -25,766,670 ▼ € 16.1 million vs 2023 (€ -9,639,095) Unfavourable step	€ 545,841 Profit after taxes 2025: € 545,841 ▲ € 26.3 million vs 2024 (€ -25,766,670) Favourable step	▲ € 26.3 million
Equity	€ 26,671,851 Equity 2021: € 26,671,851 First fiscal year in the series	€ 15,949,294 Equity 2023: € 15,949,294 ▼ 40% vs 2021 (€ 26,671,851) Unfavourable step	€ -9,817,376 Equity 2024: € -9,817,376 ▼ € 25.8 million vs 2023 (€ 15,949,294) Unfavourable step	€ 2,728,465 Equity 2025: € 2,728,465 ▲ € 12.5 million vs 2024 (€ -9,817,376) Favourable step	▲ € 12.5 million
Total debts	€ 25,277,509 Total debts 2021: € 25,277,509 First fiscal year in the series	€ 37,264,927 Total debts 2023: € 37,264,927 ▲ 47% vs 2021 (€ 25,277,509) Unfavourable step	€ 38,096,346 Total debts 2024: € 38,096,346 ▲ 2% vs 2023 (€ 37,264,927) Unfavourable step	€ 25,596,037 Total debts 2025: € 25,596,037 ▼ 33% vs 2024 (€ 38,096,346) Favourable step	▼ 33%
Cash	€ 30,329 Cash 2021: € 30,329 First fiscal year in the series	€ 1,993,984 Cash 2023: € 1,993,984 ▲ € 2 million vs 2021 (€ 30,329) Favourable step	€ 7,343,319 Cash 2024: € 7,343,319 ▲ 268% vs 2023 (€ 1,993,984) Favourable step	€ 3,140,944 Cash 2025: € 3,140,944 ▼ 57% vs 2024 (€ 7,343,319) Unfavourable step	▼ 57%
Land & buildings	€ 2,289,612 Land & buildings 2021: € 2,289,612 First fiscal year in the series	€ 3,182,005 Land & buildings 2023: € 3,182,005 ▲ 39% vs 2021 (€ 2,289,612) Unchanged	€ 2,927,176 Land & buildings 2024: € 2,927,176 ▼ 8% vs 2023 (€ 3,182,005) Unchanged	€ 2,667,491 Land & buildings 2025: € 2,667,491 ▼ 9% vs 2024 (€ 2,927,176) Unchanged	▼ 9%
Retained profit	€ 25,171,851 Retained profit 2021: € 25,171,851 First fiscal year in the series	€ 14,180,694 Retained profit 2023: € 14,180,694 ▼ 44% vs 2021 (€ 25,171,851) Unfavourable step	€ -11,585,976 Retained profit 2024: € -11,585,976 ▼ € 25.8 million vs 2023 (€ 14,180,694) Unfavourable step	€ 1,959,865 Retained profit 2025: € 1,959,865 ▲ € 13.5 million vs 2024 (€ -11,585,976) Favourable step	▲ € 13.5 million
Dividend	€ 750,000 Dividend 2021: € 750,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2021 (€ 750,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 10,291,631 Bank debt 2021: € 10,291,631 First fiscal year in the series	€ 24,706,376 Bank debt 2023: € 24,706,376 ▲ 140% vs 2021 (€ 10,291,631) Unfavourable step	€ 24,552,270 Bank debt 2024: € 24,552,270 ▼ 1% vs 2023 (€ 24,706,376) Favourable step	€ 15,439,762 Bank debt 2025: € 15,439,762 ▼ 37% vs 2024 (€ 24,552,270) Favourable step	▼ 37%
Balance sheet total	€ 52,153,033 Balance sheet total 2021: € 52,153,033 First fiscal year in the series	€ 53,381,196 Balance sheet total 2023: € 53,381,196 ▲ 2% vs 2021 (€ 52,153,033) Unchanged	€ 28,427,596 Balance sheet total 2024: € 28,427,596 ▼ 47% vs 2023 (€ 53,381,196) Unchanged	€ 28,454,455 Balance sheet total 2025: € 28,454,455 Unchanged (€ 28,427,596) Unchanged
Employees (FTE)	43 Employees (FTE) 2021: 43 First fiscal year in the series	48.9 Employees (FTE) 2023: 48.9 ▲ 5.9 vs 2021 (43) Unchanged	47.6 Employees (FTE) 2024: 47.6 ▼ 1.3 vs 2023 (48.9) Unchanged	50.5 Employees (FTE) 2025: 50.5 ▲ 2.9 vs 2024 (47.6) Unchanged	▲ 2.9

Key figures of V.M.D., fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to V.M.D.?

What happened at V.M.D. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 René Lindell stepped down as director. NBB
2031 Niclas Lindstedt stepped down as director. NBB
2031 Mikko Kemppainen stepped down as director. NBB
May 27, 2026 New annual accounts for financial year 2025: profit of € 545,841. Source: NBB ↗
2025 René Lindell became a director. NBB
2025 Niclas Lindstedt became a director. NBB
2025 Mikko Kemppainen became a director. NBB
Dec 1, 1973 New establishment in Arendonk. KBO

In short

From € 1.6 million profit in 2021 to € 545,841 profit in 2025.

Paid € 781,342 in corporate taxes since 2021.

Best year ever: 2021, with € 1.6 million profit.

Paid out € 750,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

V.M.D.

INOVET INDOCHINE COMPANY LIMITED 100%

Biove Laboratoires SAS 100%

It owns 100% of INOVET INDOCHINE COMPANY LIMITED and 100% of Biove Laboratoires SAS itself.

Directors

According to the 2025 annual accounts

René Lindell

Director

since 2025 · until 2031

Niclas Lindstedt

Director

since 2025 · until 2031

Mikko Kemppainen

Director

since 2025 · until 2031

Establishments

Establishment units

Physical locations of this company

Registered office

Hoge Mauw 900

2370 Arendonk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS inovet.eu

Canonical: https://inovet.eu/nl-be/

About

Technologies

ASP.NETCookie ConsentD3.jsGoogle AnalyticsGoogle FontsGoogle Tag ManagerKlaviyoOptimizelyPWAVarnishVimeoYouTube Embed

Hosting & Email

Email provider

Microsoft 365

Hosting

FASTLY - Fastly, Inc., US

Domain

inovet.eu

Registrar

Combell NV

Website info

HTTPS Ja

Indexable pages 15,560

Languages EN, FR, HU, NL, VI

Features

Webshop Blog Jobs Client portal Ads Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ Load balancing

Details

Company number

0413.622.648

VAT number

BE 0413.622.648

Registered office

Hoge Mauw 900, 2370 Arendonk

Names & denominations

V.M.D.

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

30 November 1973

Peppol

Active · Active since 30 Dec 2025

Contact

inovet.eu [email protected]

Activities · NACE

Vervaardiging van geneesmiddelen

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

V.M.D.

Warning lights

Financials

What happened to V.M.D.?

Management

Directors

Establishments

Establishment units

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions